| pubmed-article:10748422 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10748422 | lifeskim:mentions | umls-concept:C0005767 | lld:lifeskim |
| pubmed-article:10748422 | lifeskim:mentions | umls-concept:C0282636 | lld:lifeskim |
| pubmed-article:10748422 | lifeskim:mentions | umls-concept:C0024485 | lld:lifeskim |
| pubmed-article:10748422 | lifeskim:mentions | umls-concept:C0182400 | lld:lifeskim |
| pubmed-article:10748422 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:10748422 | pubmed:dateCreated | 2000-5-2 | lld:pubmed |
| pubmed-article:10748422 | pubmed:abstractText | Optically enhanced NMR with (129)Xe and (3)He is emerging as a novel and promising technique for medical imaging of lungs and other tissues. Here it is shown that hyperpolarized (129)Xe NMR provides a powerful means of measuring blood oxygenation quantitatively and noninvasively. The interaction of xenon with hemoglobin is responsible for an oxygen-dependent NMR shift of (129)Xe in red blood cells, in sharp contrast to the current model of xenon-hemoglobin binding. This effect could be exploited in brain functional studies, and in the assessment of conditions and diseases affected by blood oxygenation. | lld:pubmed |
| pubmed-article:10748422 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10748422 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10748422 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10748422 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10748422 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10748422 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10748422 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10748422 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:10748422 | pubmed:issn | 0740-3194 | lld:pubmed |
| pubmed-article:10748422 | pubmed:author | pubmed-author:LeachM OMO | lld:pubmed |
| pubmed-article:10748422 | pubmed:author | pubmed-author:CherubiniAA | lld:pubmed |
| pubmed-article:10748422 | pubmed:author | pubmed-author:BifoneAA | lld:pubmed |
| pubmed-article:10748422 | pubmed:author | pubmed-author:WolberJJ | lld:pubmed |
| pubmed-article:10748422 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10748422 | pubmed:volume | 43 | lld:pubmed |
| pubmed-article:10748422 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10748422 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10748422 | pubmed:pagination | 491-6 | lld:pubmed |
| pubmed-article:10748422 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
| pubmed-article:10748422 | pubmed:meshHeading | pubmed-meshheading:10748422... | lld:pubmed |
| pubmed-article:10748422 | pubmed:meshHeading | pubmed-meshheading:10748422... | lld:pubmed |
| pubmed-article:10748422 | pubmed:meshHeading | pubmed-meshheading:10748422... | lld:pubmed |
| pubmed-article:10748422 | pubmed:meshHeading | pubmed-meshheading:10748422... | lld:pubmed |
| pubmed-article:10748422 | pubmed:meshHeading | pubmed-meshheading:10748422... | lld:pubmed |
| pubmed-article:10748422 | pubmed:meshHeading | pubmed-meshheading:10748422... | lld:pubmed |
| pubmed-article:10748422 | pubmed:meshHeading | pubmed-meshheading:10748422... | lld:pubmed |
| pubmed-article:10748422 | pubmed:meshHeading | pubmed-meshheading:10748422... | lld:pubmed |
| pubmed-article:10748422 | pubmed:year | 2000 | lld:pubmed |
| pubmed-article:10748422 | pubmed:articleTitle | Hyperpolarized 129Xe NMR as a probe for blood oxygenation. | lld:pubmed |
| pubmed-article:10748422 | pubmed:affiliation | CRC Clinical Magnetic Resonance Research Group, Institute of Cancer Research, The Royal Marsden NHS Trust, Sutton, Surrey, UK. | lld:pubmed |
| pubmed-article:10748422 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10748422 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10748422 | lld:pubmed |
